Vice Chair, Chief of Spine
Barrow Neurological Institute
Phoenix, Arizona, United States
Dr. Juan S. Uribe, MD, FAANS, is the Chief Division of Spinal Disorders and Vice Chairman of Neurosurgery at Barrow Neurological Institute (BNI). Dr. Uribe completed double neurosurgical residency training at the Universidad de Antioquia in Colombia and the University of South Florida in Tampa, FL. Given his interest in the spine, Dr. Uribe completed a clinical complex spine fellowship at the University of Miami and the Miami Project to Cure Paralysis.
With over two decades of research experience, Dr. Uribe leads interdisciplinary, collaborative teams to achieve novel research discoveries. He serves as the Volker K.H. Sonntag Chair of Spine Research. His research focus is advancing the technologies and techniques in minimally invasive surgery. Additional research interests include anatomical, biomechanical, and clinical studies of applying minimally invasive spine surgery to complex traumatic injuries, tumors, and degenerative diseases.
Aligning with his clinical endeavors and research pursuits, Dr. Uribe has lectured extensively on minimally invasive spine surgery at both national and international conferences. Dr. Uribe has expanded the use of minimally invasive techniques in complex spine pathologies and has trained spine surgeons in six continents. His publication record includes numerous book chapters and over two hundred peer reviewed journal articles.
Sunday, April 23, 2023
4:29pm – 4:37pm PST
Disclosure(s): Mainstay Medical: Consultant (Ongoing); misonix: Consultant (Ongoing); NuVasive, Inc: Royalty Recipient (Ongoing); SI Bone: Consultant (Ongoing); Viseon, Inc: Consultant (Ongoing)
(NC5502) Expert Pannels and Future Impact on Deicison Making
Monday, April 24, 2023
10:00am – 10:14am PST
Disclosure(s): Mainstay Medical: Consultant (Ongoing); misonix: Consultant (Ongoing); NuVasive, Inc: Royalty Recipient (Ongoing); SI Bone: Consultant (Ongoing); Viseon, Inc: Consultant (Ongoing)
(NC5502) MIS Strategies Current and Future Which Permit Effective Treatment
Monday, April 24, 2023
1:00pm – 1:14pm PST
Disclosure(s): Mainstay Medical: Consultant (Ongoing); misonix: Consultant (Ongoing); NuVasive, Inc: Royalty Recipient (Ongoing); SI Bone: Consultant (Ongoing); Viseon, Inc: Consultant (Ongoing)
(NC5502) Panel Discussion-contemporary Mgmt of Degenerative Scoliosis , Questions Left Unanswered
Monday, April 24, 2023
1:15pm – 1:44pm PST
Disclosure(s): Mainstay Medical: Consultant (Ongoing); misonix: Consultant (Ongoing); NuVasive, Inc: Royalty Recipient (Ongoing); SI Bone: Consultant (Ongoing); Viseon, Inc: Consultant (Ongoing)